Anna Gschwend

Treatment with IL5-/IL-5 receptor antagonists in drug reaction with eosinophilia and systemic symptoms (DRESS)

A. Helbling, Cordula Meincke, K. Heidemeyer, 2022, Allergo Journal International.

75% negative skin test results in patients with suspected hypersensitivity to beta-lactam antibiotics: Influencing factors and interpretation of test results

P. Schmid‐Grendelmeier, M. Glatz, A. Helbling, 2021, The World Allergy Organization journal.

Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease

A. Rauch, D. Sidler, A. Helbling, 2022, PloS one.

Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy.

C. Akdis, M. Akdiş, M. Sokolowska, 2020, The Journal of allergy and clinical immunology.

Healthcare provision for insect venom allergy patients during the COVID-19 pandemic

K. Schäkel, G. Sturm, T. Jakob, 2020, Allergo Journal International.

Treatment with IL5-/IL-5 receptor antagonists in drug reaction with eosinophilia and systemic symptoms (DRESS)

A. Helbling, Cordula Meincke, K. Heidemeyer, 2022, Allergo Journal International.

Delayed hypersensitivity reaction to orodispersible budesonide in a case with eosinophilic esophagitis

A. Straumann, A. Helbling, T. Greuter, 2020, BMC Gastroenterology.